WCCT Global Clinical Research Executive Team
Kenneth T. Kim, MD: CEO
Dr. Kenneth Kim, a summa cum laude graduate of Harvard College, received his MD from Harvard Medical School. Following a fellowship at the MIT Sloan School of Management, he completed his internal medicine and allergy/immunology training at UCLA. He is the founder and CEO of WCCT Global LLC, an early phase drug development clinical CRO, based in the United States with 180 beds in 2 locations. Dr. Kim has served as a medical monitor, consultant, or investigator on over 500 clinical trials, having published over 30 research articles and 50 abstracts in peer reviewed journals. He has presented to the FDA on challenges and strategies of dose selection and study design for pediatric trials and met key decision makers at the PMDA, SFDA, and KFDA. He has spoken at multiple national and international meetings and is a well recognized expert in the areas of clinical pharmacology, ethnobridging, and respiratory and allergic diseases.
Jon Rojas, Chief Operating Officer
Mr. Rojas has over 12 years of clinical research experience (having conducted over 1500 trials) in the CRO industry.
Prior to joining West Coast Clinical Trials, LLC (WCCT), Mr. Rojas served as Sr. Vice President of Clinical Services & Support at OmniComm. In his role there, he managed global teams that designed, implemented and supported all of the clinical trial management (EDC) systems. In addition, part of his responsibilities included expanding global project management as Vice President of Project Management. Prior to working for OmniComm, Mr. Rojas was Executive Director of Clinical Operations at SFBC International (now doing business as PharmaNet Development Group, Inc.). Mr. Rojas was responsible for managing a 500+ bed clinical research unit with over 700 employees. In addition to clinical operations; Mr. Rojas implemented project management, clinical trial management, clinical trial monitoring, SOP and training functions. Mr. Rojas was also the clinical operations manager of a 50 bed QTc specialty unit which performed over a 100 QTc trials.
Mr. Rojas has delivered a multitude of educational presentations at key industry meetings such as DIA, EDC & Beyond and ACRP.
Mel Affrime: Senior Vice President, Translational Medicine
30+ years of clinical research experience
Co-Founder of an Academic Clinical Pharmacology Unit
Served as Chief Scientific Officer for a major global CRO & VP and Global Head of Early Development for two major Pharma companies
Designed and successfully implemented early development programs for more than 15 successfully marketed products
Lee Barsky, MBA/MHA, PMP: Vice President, Global Clinical Development
17 years of clinical research experience
Has a balanced perspective, having worked for big pharma, CROs, and specialty research providers
Responsible for the successful design and implementation of 1,000+ clinical trials across multiple therapeutic areas
Expertise in Global Project Management, Clinical Operations/Clinical Development, & Data Management
Talia Nikolao, MBA: Vice President, Business Development
10 years of clinical research experience
Experienced in the areas of Project Management, Clinical Operations, and Budgets/Contracts management
Managed multi-site phase III trials at a mid-sized Pharma company
Dave Peters, Chief Financial Officer
Dave Peters has over 17 Years of experience in the CRO industry. Dave Peters experience ranges from being with inVentiv Health where he held several senior positions, including CFO of the CRO segment and Sr. VP of Commercial and Corporate Development. Dave Peters also was part of ICON Clinical Research for 15 years where served on the Senior team that took the company through the release of their IPO.